Gambogic acid counteracts mutant p53 stability by inducing autophagy
- 1 February 2017
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1864 (2) , 382-392
Abstract
No abstract availableKeywords
Funding Information
- Italian Association for Cancer Research (5506)
- Compagnia di San Paolo (2012.1590)
- Ministry of Health (5x1000)
This publication has 49 references indexed in Scilit:
- Mutant p53: one name, many proteinsGenes & Development, 2012
- Mutant p53 Protein Is Targeted by Arsenic for Degradation and Plays a Role in Arsenic-mediated Growth SuppressionJournal of Biological Chemistry, 2011
- Dominant-Negative Features of Mutant TP53 in Germline Carriers Have Limited Impact on Cancer OutcomesMolecular Cancer Research, 2011
- Gambogic acid‐induced degradation of mutant p53 is mediated by proteasome and related to CHIPJournal of Cellular Biochemistry, 2010
- PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cellsBiochemical and Biophysical Research Communications, 2010
- The Role of Ubiquitin in Autophagy-Dependent Protein Aggregate ProcessingGenes & Cancer, 2010
- Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancerProceedings of the National Academy of Sciences, 2010
- Chaperone-dependent stabilization and degradation of p53 mutantsOncogene, 2008
- Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathwayBlood, 2007
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005